| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 715 | 2003 |
| Hepatitis A booster vaccination: is there a need? P Van Damme, J Banatvala, O Fay, S Iwarson, B McMahon, K Van Herck, ... The lancet 362 (9389), 1065-1071, 2003 | 305 | 2003 |
| Health literacy and vaccination: A systematic review C Lorini, F Santomauro, M Donzellini, L Capecchi, A Bechini, S Boccalini, ... Human vaccines & immunotherapeutics 14 (2), 478-488, 2018 | 285 | 2018 |
| Fake news and Covid-19 in Italy: results of a quantitative observational study A Moscadelli, G Albora, MA Biamonte, D Giorgetti, M Innocenzio, S Paoli, ... International journal of environmental research and public health 17 (16), 5850, 2020 | 222 | 2020 |
| Varicella vaccination in Europe–taking the practical approach P Bonanni, J Breuer, A Gershon, M Gershon, W Hryniewicz, ... BMC medicine 7, 1-12, 2009 | 194 | 2009 |
| An overview of quadrivalent human papillomavirus vaccine safety: 2006 to 2015 M Vichnin, P Bonanni, NP Klein, SM Garland, SL Block, SK Kjaer, ... The Pediatric infectious disease journal 34 (9), 983-991, 2015 | 188 | 2015 |
| Varicella vaccination-the global experience P Wutzler, P Bonanni, M Burgess, A Gershon, MA Sáfadi, G Casabona Expert review of vaccines 16 (8), 833-843, 2017 | 177 | 2017 |
| Vaccine strategies: Optimising outcomes K Hardt, P Bonanni, S King, JI Santos, M El-Hodhod, GD Zimet, S Preiss Vaccine 34 (52), 6691-6699, 2016 | 153 | 2016 |
| Vaccine safety evaluation: practical aspects in assessing benefits and risks A Di Pasquale, P Bonanni, N Garçon, LR Stanberry, M El-Hodhod, ... Vaccine 34 (52), 6672-6680, 2016 | 146 | 2016 |
| Demographic impact of vaccination: a review P Bonanni Vaccine 17, S120-S125, 1999 | 140 | 1999 |
| The prevention of infection-associated cancers S De Flora, P Bonanni Carcinogenesis 32 (6), 787-795, 2011 | 134 | 2011 |
| Attitudes and beliefs on influenza vaccination during the COVID-19 pandemic: results from a representative Italian survey A Domnich, M Cambiaggi, A Vasco, L Maraniello, F Ansaldi, V Baldo, ... Vaccines 8 (4), 711, 2020 | 128 | 2020 |
| Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy P Bonanni, G Pesavento, A Bechini, E Tiscione, F Mannelli, C Benucci, ... Vaccine 21 (7-8), 685-691, 2003 | 128 | 2003 |
| Recommended vaccinations for asplenic and hyposplenic adult patients P Bonanni, M Grazzini, G Niccolai, D Paolini, O Varone, A Bartoloni, ... Human vaccines & immunotherapeutics 13 (2), 359-368, 2017 | 127 | 2017 |
| The remaining challenges of pneumococcal disease in adults E Ludwig, P Bonanni, G Rohde, A Sayiner, A Torres European Respiratory Review 21 (123), 57-65, 2012 | 125 | 2012 |
| Epidemiology and prevention of respiratory syncytial virus infections in children in Italy C Azzari, E Baraldi, P Bonanni, E Bozzola, A Coscia, M Lanari, P Manzoni, ... Italian Journal of Pediatrics 47, 1-12, 2021 | 124 | 2021 |
| Vaccination against hepatitis B in health care workers P Bonanni, G Bonaccorsi Vaccine 19 (17-19), 2389-2394, 2001 | 120 | 2001 |
| Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms R Guerrini, R Carrozzo, R Rinaldi, P Bonanni Pediatric Drugs 5, 647-661, 2003 | 119 | 2003 |
| Vaccine coverage in Italy and assessment of the 2012-2014 National Immunization Prevention Plan P Bonanni, A Ferro, R Guerra, S Iannazzo, A Odone, MG Pompa, ... Epidemiol Prev 39 (4 Suppl 1), 146-58, 2015 | 115 | 2015 |
| Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence P Bonanni, S Boccalini, A Bechini Vaccine 27, A46-A53, 2009 | 112 | 2009 |
